Strattera Oral capsule 40mg Information - Conditions, Pregnancy, ingredients
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

Strattera: Oral capsule (40mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Most Commonly Used
Drug Image file DrugItem_5419.JPG
Strattera 40mg Cap
Eli Lilly and Co
Pill Identification: Lilly 3229 40 mg 

What is this Medicine?

ATOMOXETINE (AT oh mox e teen) is used to treat attention deficit/hyperactivity disorder, also known as ADHD. It is not a stimulant like other drugs for ADHD. This drug can improve attention span, concentration, and emotional control. It can also reduce restless or overactive behavior.

CVS/pharmacy Patient Statistics for Strattera: Oral capsule(40mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Strattera 40mg Capsule

NDC: 000023229
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Attention-deficit Hyperactivity Disorder (ADHD)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Strattera 40mg Capsule
Drug Image file DrugItem_5419.JPG
Eli Lilly and Co
Pill Identification: Lilly 3229 40 mg 
Shape: capsule
Color: blue

Reported Side Effects for Strattera 40mg Capsule

Paresthesias Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Irregular Periods Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
<0.8%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
<0.6%*
Severity: MODERATE
Onset: EARLY
Orgasm Dysfunction Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Large Pupil Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
<3.0%*
Severity: MILD
Onset: RAPID
Increased Urination Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Testicular Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Restlessness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Urinary Urgency Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Prostate Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Convulsions Incidence:
0.1-0.2%*
Severity: SEVERE
Onset: DELAYED
Mania Incidence:
0.2%*
Severity: MODERATE
Onset: EARLY
Postural Low Blood Pressure Incidence:
0.2-1.8%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
0.2%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
0.3-1.5%*
Severity: MODERATE
Onset: RAPID
Hostility Incidence:
0.4-1.6%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
0.4%*
Severity: MILD
Onset: DELAYED
Thoughts Of Suicide Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Conjunctivitis Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Emotional Lability Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
2.0-29.1%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
2.0-19.0%*
Severity: MILD
Onset: EARLY
Menstrual Cramps Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
3.0%*
Severity: MILD
Onset: RAPID
Decreased Appetite Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Decreased Sexual Desire Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Ejaculation Dysfunction Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
4.0-11.0%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
4.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Irritability Incidence:
5.0-6.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
5.0-8.0%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
6.0-10.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
7.0-18.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0-26.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
8.0-11.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
20.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Strattera 40mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Strattera 40mg Capsule(Atomoxetine Hydrochloride)
Alcohol and Atomoxetine Hydrochloride(Atomoxetine Hydrochloride)
Avoid alcoholic drinks, and medicines containing significant amounts of alcohol while taking Atomoxetine. You may feel drowsy or more tired when taking Atomoxetine and Alcoholic beverages together. Do not drive or operate machinery until you know how these drugs affect you.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Strattera

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5